Bright Minds Biosciences Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Net Income	-5.24	-7.37	-14.96	-8.65	-0.48	-0.08
Depreciation & Amortization	0.07	0.07	0.01	0	0	0
Share-Based Compensation	1.08	1.15	0.88	1.25	0.16	0
Other Operating Activities	-0.39	-0.88	0.5	0.08	0.03	0.04
Operating Cash Flow	-4.48	-7.02	-13.59	-7.32	-0.29	-0.04
Share Issuance / Repurchase	0.9	1.22	4.35	27.76	1.01	0.12
Debt Issued / Paid	-0.09	-0.09	-0.01	0	0	0
Other Financing Activities	-	1.06	0.85	-1.71	-	-
Financing Cash Flow	0.81	2.19	5.2	26.06	1.01	0.12
Exchange Rate Effect	-0.08	-0.05	0.26	0.22	0	0
Net Cash Flow	-3.66	-4.83	-8.39	18.74	0.72	0.08
Free Cash Flow	-4.48	-7.02	-13.59	-7.32	-0.29	-0.04
Free Cash Flow Per Share	-1.00	-1.89	-5.50	-4.08	-0.40	-0.10

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).